Furthermore, constitutive activation of the NFκB pathway is a hallmark of several types of tumors including SCCs [25], [26], [27] while its inhibition is a known chemoprevention for several tumor types (reviewed in [28]). The gene discussed is NFKB1; the disease is neoplasm.